Tarsus Pharmaceuticals (TARS) Tax Provisions (2020 - 2026)
Tarsus Pharmaceuticals (TARS) recorded quarterly Tax Provisions of $2.4 million in Q1 2026, up 47140.0% quarter-over-quarter from -$5000.0 in Q3 2022.
Tarsus Pharmaceuticals (TARS) Tax Provisions (2020 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' Tax Provisions history runs 4 years deep, the most recent figure standing at $2.4 million for Q1 2026.
- In Q1 2026, Tax Provisions changed N/A year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $2.4 million (changed N/A YoY), while the FY2025 annual figure was $2.1 million, changed N/A from the prior year.
- Tax Provisions was $2.4 million for Q1 2026 at Tarsus Pharmaceuticals, up from -$5000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $2.4 million in Q1 2026 to a low of -$5000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Tarsus Pharmaceuticals | 2.71 Bn | 2.61 Bn | 152.66 Mn | 2.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.35 Mn |
| Sep 30, 2022 | -5,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 54,000.00 |
| Sep 30, 2021 | -341,000.00 |
| Jun 30, 2021 | 29,000.00 |
| Mar 31, 2021 | 313,000.00 |
| Sep 30, 2020 | 1,000.00 |